Medication info

Rosurol Tablet 2.5 mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›2.6mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
White round film-coated tablet
Packaging
PTP - 30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 202302170 · Approved 2023.07.14

Summary

Main use
Improvement of primary hypercholesterolemia and mixed hyperlipidemia
Who uses it
Adults
Adult dosage
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 2.5 or 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams once daily. Elderly patients: No dosage adjustment is required. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering this medicine at a dose of 20mg to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 2.5 or 5 milligrams. A dose of 40 milligrams is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 2.5 or 5 milligrams. A dose of 40 milligrams is contraindicated in some of these patients.

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed hyperlipidemia
View approved original text

This medication is used for patients with primary hypercholesterolemia and heterozygous familial hypercholesterolemia (primarily type IIa), as well as mixed hyperlipidemia (type IIb). It is primarily prescribed as an adjunct to dietary management when not adequately controlled by diet and exercise. This helps manage blood cholesterol levels and reduce the risk of cardiovascular disease. Patients can effectively improve their hyperlipidemia by taking this medication alongside consistent dietary therapy.

Dosage and Administration

Adult dosage

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 2.5 or 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams once daily. Elderly patients: No dosage adjustment is required. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering this medicine at a dose of 20mg to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 2.5 or 5 milligrams. A dose of 40 milligrams is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 2.5 or 5 milligrams. A dose of 40 milligrams is contraindicated in some of these patients.

Precautions

This medication should not be administered to certain patients. For example, patients allergic to any components of this medication, those with severe liver dysfunction, those with muscle disorders, and women who are pregnant or breastfeeding should not take this medication. Additionally, this medication may be contraindicated in patients with severely impaired kidney function or those taking certain medications; therefore, caution is needed. Women of childbearing potential should only take this medication when pregnancy is unlikely and must use appropriate contraception. This medication can affect liver function and muscle health, so individuals who consume alcohol excessively or have a history of liver disease should undergo liver function tests before taking it. If symptoms of muscle pain or weakness develop, healthcare professionals should be notified immediately, and in severe cases, medication may be discontinued. Regular monitoring of kidney function is necessary, especially during high-dose administration, as it can impact kidney function. Asian patients may require dosage adjustments due to higher drug concentrations. This medication can rarely cause serious skin reactions or liver damage; therefore, if severe rashes or symptoms like jaundice occur, you should stop taking it immediately and consult a doctor. Additionally, this medication can interact with other drugs, so if you are currently taking any medications, it is crucial to inform your healthcare provider. Especially when taken with certain antibiotics, antifungals, immunosuppressants, or lipid-lowering agents, the risk of atypical muscle reactions may increase. Pregnant or breastfeeding women should not take this medication, and women who may become pregnant must use appropriate contraception. In the case of overdose, there is no specific antidote; treatment should be symptomatic, and liver function and muscle enzyme levels should be monitored. Lastly, this medication may cause dizziness, so caution is needed when driving or operating machinery.

Side effects

Dyspepsia, pruritus, immune thrombocytopenic purpura, facial edema, herpes zoster, vulvar pruritus, hypersensitivity reactions including angioedema, diabetes mellitus, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculomotor weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, morbilliform drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, headache, dizziness, increased ALT, chest pain, cough, myalgia, increased CK, constipation, increased AST, weakness, joint pain, fatigue, numbness, abnormal sensation, chest discomfort, nausea, abdominal pain, diarrhea, loss of appetite, abdominal distension, itching, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute kidney failure, oliguria, increased serum creatinine

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. The recommended storage temperature is between 1 and 30 degrees Celsius to maintain the effectiveness of the medication.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

PTP - 30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.